For some individuals a genetic deficiency in AAT can be identified as the driving force behind the development of early onset of COPD with risk substantially increased when circulating levels of AAT fall below the protective threshold of 11 μM (50 mg/dL). Here, SERPINA1 is linked to chronic obstructive pulmonary disease.